Literature DB >> 15869579

Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG).

N Tsuchida-Straeten1, S Ensslen, C Schäfer, M Wöltje, B Denecke, M Moser, S Gräber, S Wakabayashi, T Koide, W Jahnen-Dechent.   

Abstract

Histidine-rich glycoprotein (HRG) is a serum protein belonging to the cystatin superfamily. HRG may play a regulatory role in hemostasis and innate immunity. However, this role is uncertain because of a lack of rigorous testing in an animal model. We generated mice lacking the translation start point of exon 1 of the Hrg gene, effectively resulting in a null mutation (Hrg-/-). The mice were viable and fertile but had no HRG in their blood. Antithrombin activity in the plasma of Hrg-/- mice was higher than in the plasma of heterozygous Hrg+/- or wild-type Hrg+/+ mice. The prothrombin time was shorter in Hrg-/- mice than in Hrg+/- and Hrg+/+ mice. Bleeding time after tail tip amputation in Hrg-/- mice was shorter than in Hrg+/+ mice. The spontaneous fibrinolytic activity in clotted blood of Hrg-/- mice was higher than in Hrg+/+ mice. These findings suggest that HRG plays a role as both an anticoagulant and an antifibrinolytic modifier, and may regulate platelet function in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15869579     DOI: 10.1111/j.1538-7836.2005.01238.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  29 in total

1.  Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II.

Authors:  Matthew Ndonwi; Oname O Burlingame; Aaron S Miller; Douglas M Tollefsen; George J Broze; Daniel E Goldberg
Journal:  Blood       Date:  2011-04-21       Impact factor: 22.113

2.  Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.

Authors:  Weihong Tang; Christine Schwienbacher; Lorna M Lopez; Yoav Ben-Shlomo; Tiphaine Oudot-Mellakh; Andrew D Johnson; Nilesh J Samani; Saonli Basu; Martin Gögele; Gail Davies; Gordon D O Lowe; David-Alexandre Tregouet; Adrian Tan; James S Pankow; Albert Tenesa; Daniel Levy; Claudia B Volpato; Ann Rumley; Alan J Gow; Cosetta Minelli; John W G Yarnell; David J Porteous; John M Starr; John Gallacher; Eric Boerwinkle; Peter M Visscher; Peter P Pramstaller; Mary Cushman; Valur Emilsson; Andrew S Plump; Nena Matijevic; Pierre-Emmanuel Morange; Ian J Deary; Andrew A Hicks; Aaron R Folsom
Journal:  Am J Hum Genet       Date:  2012-06-14       Impact factor: 11.025

3.  Histidine-Rich Glycoprotein Stimulates Human Neutrophil Phagocytosis and Prolongs Survival through CLEC1A.

Authors:  Yohei Takahashi; Hidenori Wake; Masakiyo Sakaguchi; Yukinori Yoshii; Kiyoshi Teshigawara; Dengli Wang; Masahiro Nishibori
Journal:  J Immunol       Date:  2021-01-15       Impact factor: 5.422

4.  Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

5.  Plasmodium falciparum histidine rich protein HRPII inhibits the anti-inflammatory function of antithrombin.

Authors:  Peyman Dinarvand; Likui Yang; Indranil Biswas; Hemant Giri; Alireza R Rezaie
Journal:  J Thromb Haemost       Date:  2020-01-14       Impact factor: 5.824

6.  Whole-exome sequencing in evaluation of patients with venous thromboembolism.

Authors:  Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee
Journal:  Blood Adv       Date:  2017-06-29

7.  Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation.

Authors:  Hunter B Moore; Ernest E Moore; Alexander P Morton; Eduardo Gonzalez; Miguel Fragoso; Michael P Chapman; Monika Dzieciatkowska; Kirk C Hansen; Anirban Banerjee; Angela Sauaia; Christopher C Silliman
Journal:  J Trauma Acute Care Surg       Date:  2015-12       Impact factor: 3.313

8.  Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein.

Authors:  Trang T Vu; Ji Zhou; Beverly A Leslie; Alan R Stafford; James C Fredenburgh; Ran Ni; Shengjun Qiao; Nima Vaezzadeh; Willi Jahnen-Dechent; Brett P Monia; Peter L Gross; Jeffrey I Weitz
Journal:  Blood       Date:  2015-02-17       Impact factor: 22.113

Review 9.  Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems.

Authors:  Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

10.  Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors.

Authors:  Benjamin Theek; Maike Baues; Felix Gremse; Robert Pola; Michal Pechar; Inka Negwer; Kaloian Koynov; Benjamin Weber; Matthias Barz; Willi Jahnen-Dechent; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  J Control Release       Date:  2018-05-04       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.